Abstract

AN IN SILICO APPROACH FOR COMPUTING THE EFFICACIES OF COMPASSIONATELY PRESCRIBING ANTIVIRALS FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS COV-2) INFECTED PATIENTS

Abhilash Mullasseril*

Abstract

The 2020 year began with a news of neglected/mishandled viral outbreak of the last year 2019 that turned to a pandemic zoon which caused many casualties and lead to a complete lock down all over the world. In this present research paper the results of in silico evaluation of the otherwise proven antiviral drugs using computational methodologies against the published main protease (6yb7.pdb) of novel SARS CoV-2 virus. The selection of drug moleccules was achieved by randomely selecting them from the contemperory medical literatures.

Keywords: SARS CoV-2, COVID 19, Antivirals, Computational Studies, Docking.